Annual General Meeting 2025

Voting results

Information in accordance with Table 8 of the Annex to the Implementing Regulation (EU) 2018/1212

Dividend announcement

Invitation and agenda

Link to Shareholder Portal

Information pursuant to Section 125 AktG in accordance with Table 3 of the Annex of the Implementing Regulation (EU) 2018/1212

Form for shareholders to authorize a proxy and issue instructions (German)

Explanations on the rights of shareholders

Data protection information for shareholders and their proxies

Directions to the Annual General Meeting (German)

Annual Financial Statements and management report in accordance with HGB for the fiscal year 2024 (including the Managment Board's proposal for the appropriation of net retained profits) (German)

Annual Report 2024 (including consolidated financial statements and group management report in accordance with IFRS and Sustainability Statement for the fiscal year 2024)

Report by the Supervisory Board 2024

Explanatory report by the Management Board pursuant to Sections 289a, 315a HGB

Peter Kartscher has been the responsible German Public Auditor since 2020 and will be the responsible Auditor for the last time in 2024. 

Compensation Report 2024

Report by the Management Board regarding agenda item 7

Overview of the amendments to Article 4 of the Articles of Association proposed under agenda item 7

Report by the Management Board regarding agenda item 8

Overview of the amendments to Article 15 of the Articles of Association proposed under agenda item 9

Overview of the amendments to Article 10 of the Articles of Association proposed under agenda item 10

Declaration on Corporate Governance

Form 20-F for the fiscal year 2024

Articles of Association

Below you find the countermotion from a shareholder within the meaning of Section 126 of the German Stock Corporation Act (Aktiengesetz) on item 3 of the agenda of the Annual General Meeting of Fresenius Medical Care AG on May 22, 2025. 

The countermotion can be supported by voting “No” on item 3 of the agenda or by issuing a corresponding voting instruction.

The countermotion and the reasoning reflect the views of the person who submitted them. Assertions of fact and hyperlinks to third-party websites were also posted on the internet unchanged and unchecked by us to the extent that they are required to be disclosed. Fresenius Medical Care does not assume any responsibility for said content, nor does it endorse said websites and their content.

In particular, making the countermotion and its grounds available does not imply any acknowledgement of the correctness of the statements or evaluations contained therein.

The countermotion is only available in German, as submitted by the shareholder.

Countermotion by a shareholder